VYNE Therapeutics
VYNE
#10308
Rank
NZ$38.48 M
Marketcap
NZ$1.15
Share price
0.06%
Change (1 day)
-31.24%
Change (1 year)

Annual Reports (10-K)

Latest form 10-K annual reports for VYNE Therapeutics CIK: 0001566044

Thumbnail VYNE Therapeutics 10-K Annual Report

10-K Annual Report 2026-02-27

Language: English

View Annual Report (10-K)
Thumbnail VYNE Therapeutics 10-K Annual Report

10-K Annual Report 2025-03-06

Language: English

View Annual Report (10-K)
Thumbnail VYNE Therapeutics 10-K Annual Report

10-K Annual Report 2024-03-01

Language: English

View Annual Report (10-K)
Thumbnail VYNE Therapeutics 10-K Annual Report

10-K Annual Report 2023-03-14

Language: English

View Annual Report (10-K)
Thumbnail VYNE Therapeutics 10-K Annual Report

10-K Annual Report 2022-03-17

Language: English

View Annual Report (10-K)
Thumbnail VYNE Therapeutics 10-K Annual Report

10-K Annual Report 2021-03-04

Language: English

View Annual Report (10-K)
Thumbnail VYNE Therapeutics 10-K Annual Report

10-K Annual Report 2020-03-03

Language: English

View Annual Report (10-K)
Thumbnail VYNE Therapeutics 10-K Annual Report

10-K Annual Report 2019-02-28

Language: English

View Annual Report (10-K)
Thumbnail VYNE Therapeutics 10-K Annual Report

10-K Annual Report 2018-03-28

Language: English

View Annual Report (10-K)